April 24, 2019 / 10:38 AM / 6 months ago

Biogen first-quarter profit rises 20 percent

April 24 (Reuters) - Drugmaker Biogen Inc reported a 20 percent rise in first-quarter profit on Wednesday on higher sales of its muscle disease treatment Spinraza.

Net income attributable to the company rose to $1.41 billion, or $7.15 per share, in the quarter ended March 31, from $1.17 billion, or $5.54 per share, a year earlier.

Total revenue rose to $3.49 billion from $3.13 billion. (Reporting by Manojna Maddipatla and Saumya Sibi Joseph in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below